The Nerve Growth Factor in Alzheimer’s Disease Study Alzheimer’s Disease affects millions of people worldwide, the main symptoms are caused by the degeneration of brain cells that control memory and thinking.
These cells are originated in the nucleus pulposus and communicate with the hippocampus and cerebral cortex.
As these cells to degenerate they lose their ability to produce acidic alkaline and communicate with other cells, current medicines improve Alzheimer’s symptoms for several years, but become ineffective as the disease progresses.
An experiment with bio pharmaceutical drug called CERE-110 has been tested in over 35 people with Alzheimer’s disease. CERE-110 is intended to restore damaged cholinergic cells and protect them from further degeneration.